About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Parkinson's Disease Clinical Trials in Philadelphia | 5 Studies

Clinical Trials Parkinson's DiseasePhiladelphia

Parkinson's Disease Clinical Trials in Philadelphia

Find 5 clinical trials for parkinson's disease near Philadelphia, Pennsylvania. Connect with research centers in your area.

All Parkinson's Disease trials nationwide All trials in Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 1-5 of 5 trials

RecruitingA Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's DiseaseThe goal of this Phase 2 clinical trial is to investigate the efficacy and safety of NEU-411 in men and women aged 40-80 years with early Parkinson's Disease (PD) who have…NCT06680830·Sun City, Arizona and 71 others

Parkinson's Disease Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix San Antonio

Data from ClinicalTrials.govTerms

RecruitingStudy of Biodistribution, Metabolism, Excretion and Brain Uptake 18F-JSS20-183AThe current protocol is to determine the biodistribution, metabolism, excretion and brain uptake of 18F-JSS20-183A.NCT06932809·San Francisco, California and 1 other

Active not recruitingA Study to Evaluate the Efficacy and Safety of Intravenous Prasinezumab in Participants With Early Parkinson's DiseaseThis is a multicenter, randomized, double-blind, placebo-controlled study that will evaluate the efficacy and safety of intravenous (IV) prasinezumab versus placebo in…NCT04777331·Birmingham, Alabama and 109 others

RecruitingA Post-Approval Registry for Exablate 4000 Type 1.0 and Type 1.1 for Unilateral Pallidotomy for the Treatment of Advanced, Idiopathic Parkinson's Disease With Medication-refractory Moderate to Severe Motor ComplicationsThis registry is a prospective, multicenter, international, single arm, observational post-approval registry with follow-up at 3, 6, and 12 months, and annually for 5 years.NCT05539196·Baltimore, Maryland and 4 others

Not yet recruitingGamification and Physical Activity in PDDespite overwhelming evidence that exercise can improve motor and non-motor symptoms of Parkinson's Disease (PD), less than 25% of Veterans with PD meet recommended activity goals.NCT07286994·Philadelphia, Pennsylvania

Other Conditions in Philadelphia

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia